Bruker Corp BRKR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Bruker Acquires Dynamic Biosensors, a Pioneer of Single-Cell Interaction Cytometry Systems for Drug Discovery
-
Bruker Corporation to Present at Upcoming Investor Conferences
-
Bruker Announces Successful Installation of 1.2 GHz Avance® NMR Spectrometer at the Korea Basic Science Institute (KBSI)
-
Bruker Announces Quarterly Dividend
-
Bruker Announces Strategic Minority Investment in NovAliX
-
Bruker Reports Second Quarter 2024 Financial Results
-
Bruker Announces Date and Time of Second Quarter 2024 Earnings Release and Webcast
-
Bruker Announces that Injunction Impacting NanoString’s CosMx Spatial Molecular Imager Products in Germany Has Been Suspended Effective Immediately
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 26.91
- Price/Sales
- 3.15
- Dividend Yield (Trailing)
- 0.30%
- Dividend Yield (Forward)
- 0.30%
- Total Yield
- 0.30%
Company Profile
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 9,707
- Website
- https://www.bruker.com
Comparables
Valuation
|
Metric
|
BRKR
|
301122
|
688468
|
|---|---|---|---|
Price/Earnings (Normalized) | 26.91 | 31.08 | 21.05 |
Price/Book Value | 5.67 | 1.36 | 2.05 |
Price/Sales | 3.15 | 5.73 | 6.16 |
Price/Cash Flow | 27.57 | 17.61 | 14.42 |
Price/Earnings
BRKR
301122
688468
Financial Strength
|
Metric
|
BRKR
|
301122
|
688468
|
|---|---|---|---|
Quick Ratio | 0.66 | 9.53 | 4.71 |
Current Ratio | 1.65 | 11.59 | 5.48 |
Interest Coverage | 16.27 | 7,815.76 | 111.54 |
Quick Ratio
BRKR
301122
688468
Profitability
|
Metric
|
BRKR
|
301122
|
688468
|
|---|---|---|---|
Return on Assets (Normalized) | 8.17% | 3.62% | 7.46% |
Return on Equity (Normalized) | 25.98% | 3.85% | 9.59% |
Return on Invested Capital (Normalized) | 12.78% | 3.66% | 7.98% |
Return on Assets
BRKR
301122
688468
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Zqvghqsg | Fxxnnd | $196.0 Bil | |||
| Stryker Corp
SYK
| Hhqchmtcp | Lbr | $133.8 Bil | |||
| Boston Scientific Corp
BSX
| Dphfypmr | Xqskmt | $124.5 Bil | |||
| Medtronic PLC
MDT
| Dqclsphw | Xkbmzlr | $113.2 Bil | |||
| Edwards Lifesciences Corp
EW
| Bspfcrqy | Yklxh | $39.5 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Rpllr | Rzxk | $30.2 Bil | |||
| DexCom Inc
DXCM
| Tsxtfygsw | Hfzc | $27.3 Bil | |||
| Steris PLC
STE
| Phkfbjzc | Ynfpgpb | $22.8 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Lfnrjdryc | Rgk | $21.3 Bil | |||
| Insulet Corp
PODD
| Yqmckjxtm | Mtvwv | $16.1 Bil |
United States